HIV vaccine laboratory support center
HIV Vaccine Trials Network Laboratory Center
This program runs the specialized lab tests that help develop safer, more effective HIV vaccines for people at risk of HIV infection.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Fred Hutchinson Cancer Center NIH-funded |
| Lab location | 1 site (Seattle, United States) |
| Project ID | NIH-11237568 on NIH RePORTER |
What this research studies
This laboratory center leads and coordinates high-quality lab testing for the HIV Vaccine Trials Network to speed vaccine development. They run validated assays on blood and other samples to measure immune responses after vaccination and compare different vaccine types, schedules, and delivery routes. The center maintains strict quality controls so results from small early trials and large efficacy studies can be compared reliably. Their work also supports related prevention strategies and vaccine efforts for infections like tuberculosis.
Who could benefit from this research
Good fit: People at risk of HIV infection who are eligible to join HVTN vaccine trials or to donate samples to those trials (including age groups enrolled by specific studies) would be the ideal candidates to benefit.
Not a fit: People already living with HIV or those not eligible to participate in vaccine trials are unlikely to receive direct benefit from this program.
Why it matters
Potential benefit: If successful, the center could speed the discovery and selection of HIV vaccine candidates that are safer and more likely to prevent infection.
How similar studies have performed: Previous HVTN laboratory work has helped guide vaccine candidates through early and late trials, but a widely effective HIV vaccine has not yet been achieved.
Where this research is happening
Seattle, United States
- Fred Hutchinson Cancer Center — Seattle, United States (Active)
Researchers
- Principal investigator: Mcelrath, Margaret Juliana — Fred Hutchinson Cancer Center
- Study coordinator: Mcelrath, Margaret Juliana
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.